Abstract
The causes of schizophrenia remain obscure and complex to identify. Alterations in dopaminergic and serotonergic neurotransmission are, to date, the primary pharmacological targets in treatment. Underlying abnormalities in neural networks have been identified as cell adhesion molecules (CAMs) involved in synaptic remodeling and interplay between neurons-neurons and neurons-glial cells. Among the CAMs, several families have been identified, such as integrins, selectins, cadherins, immunoglobulins, nectins, and the neuroligin-neurexin complex. In this paper, cell adhesion molecules involved in the pathogenesis of schizophrenia will be described.
Reference43 articles.
1. 1. McGrath J, Saha S, Chant D, et al. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev 2008; 30:67–76.
2. 2. Eastwood SL. The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame? Int Rev Neurobiol 2004; 59:47–72.
3. 3. Pantazopoulos H, Katsel P, Haroutunian V, et al. Molecular signature of extracellular matrix pathology in schizophrenia. Eur J Neurosci 2021; 53(12):3960–87.
4. 4. Cai HQ, Weickert TW, Catts VS, et al. Altered levels of immune cell adhesion molecules are associated with memory impairment in schizophrenia and healthy controls. Brain Behav Immun 2020; 89:200–8.
5. 5. He B, Wang Y, Li H, et al. The role of integrin beta in schizophrenia: a preliminary exploration [published online ahead of print, 2022 Oct 24]. CNS Spectr 2022; 1–10.